Which has grown faster, AKBA or QTTB?

Over the past five years, QTTB grew revenue faster — AKBA at a -0.26% CAGR versus QTTB at 10.22%.

Is AKBA or QTTB more profitable?

QTTB runs the higher net margin — AKBA at -13.54% versus QTTB at 62.87%.

How have AKBA and QTTB total returns compared?

Over the past 5 years, AKBA delivered -20.07% and QTTB delivered -41.51% annualized total return. Past performance doesn't predict future results.

Akebia Therapeutics, Inc. (AKBA) vs Q32 Bio Inc. (QTTB)

A side-by-side comparison of Akebia Therapeutics, Inc. and Q32 Bio Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

AKBA

Akebia Therapeutics, Inc.

$236M

$0.88HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT

QTTB

Q32 Bio Inc.

$243M

$8.15HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT

Total return — AKBA vs QTTB

growth of $100 · dividends reinvested · last 9y

AKBA -90.7% (-23.2%/yr)QTTB -97.5% (-33.7%/yr)AKBA compounded faster over this window

AKBA QTTB

AKBA vs QTTB: by the numbers

•QTTB is the larger company ($243M vs $236M market cap).
•QTTB is profitable (62.87% net margin) while AKBA runs a net loss (-13.54%).
•QTTB grew revenue faster over the past five years (10.22% vs -0.26% CAGR).

Metrics side by side

Valuation

Metric	AKBA	QTTB
P/E ratio	N/A	2.92
P/S ratio	1.08	4.51
P/B ratio	9.45	2.29
EV / EBITDA	N/A	6.46
FCF yield	17.00%	N/A

Profitability

Metric	AKBA	QTTB
Gross margin	79.48%	99.84%
Operating margin	9.95%	31.45%
Net margin	-13.54%	62.87%
ROE	-118.58%	31.90%
ROIC	-7.08%	19.43%

Growth (annualized)

Metric	AKBA	QTTB
Revenue CAGR (5Y)	-0.26%	10.22%
Total return CAGR (5Y)	-20.07%	-41.51%

Frequently asked

Which has grown faster, AKBA or QTTB?: Over the past five years, QTTB grew revenue faster — AKBA at a -0.26% CAGR versus QTTB at 10.22%.
Is AKBA or QTTB more profitable?: QTTB runs the higher net margin — AKBA at -13.54% versus QTTB at 62.87%.
How have AKBA and QTTB total returns compared?: Over the past 5 years, AKBA delivered -20.07% and QTTB delivered -41.51% annualized total return. Past performance doesn't predict future results.

Go deeper

Full AKBA analysis Full QTTB analysis Interactive comparison tool

Dig into the metrics

Q32 Bio P/E ratio Akebia Therapeutics ROE Q32 Bio ROE Akebia Therapeutics operating margin Q32 Bio operating margin Akebia Therapeutics revenue growth Q32 Bio revenue growth Akebia Therapeutics free cash flow Q32 Bio free cash flow

Akebia Therapeutics & Q32 Bio appear in these rankings

Highest ROE Stocks Highest ROIC Stocks Highest Operating Margin Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.